Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2007 045 368.2 |
96 | EP file number | EAKZ | 11 00 2768.7 |
97 | EP publication number | EPN | 2345455 |
54 | Designation/title | TI | Lacosamid zur Behandlung von Übererregbarkeitsstörungen im Zusammenhang mit Natrium-Kanal Dysfunktionen |
51 | IPC main class | ICM (ICMV) | A61P 25/08 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/165 (2006.01), A61P 9/06 (2006.01) |
22 | DE application date | DAT | Jun 29, 2007 |
96 | EP application date | EAT | Jun 29, 2007 |
43 | Date of first publication | OT | Jul 20, 2011 |
| Date of publication of grant | PET | Mar 16, 2016 |
71/73 | Applicant/owner | INH | UCB Pharma GmbH, 40789 Monheim, DE |
72 | Inventor | IN | Beyreuther, Bettina, 40219 Düsseldorf, DE; Heers, Cara, 64293 Darmstadt, DE; Stöhr, Thomas, 2400 Mol, BE |
| Address for service | | UCB Pharma GmbH, 40789 Monheim, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 06021470 Oct 12, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 06021469 Oct 12, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 06024241 Nov 22, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 06013655 Jun 30, 2006
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002345455 Searchable text:
EP000002345455 Original document:
EP000002345455B1 Searchable text:
EP000002345455B1 |
43 | Date of first publication | EVT | Jul 20, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Sep 2, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 7, 2024 (Show all update days)(Hide all update days)- Sep 2, 2011
- Date of the first transfer into DPMAregister
|